Skip to main content

Table 1 Participants characteristics

From: Effectiveness of postoperative oral administration of cephalexin and metronidazole on surgical site infection among obese women undergoing cesarean section: a randomized, double-blind, placebo-controlled, parallel-group study—phase III

Variables

Intervention (n = 210)

Control (n = 210)

p-value

N (%)

N (%)

Pregnancy number (median)

4

4

0.920*

Past cesarean (median)

1

2

0.477*

Gestational age (weeks)

39

38

0.993*

Duration of C-section (min)

47.3

45.9

0.561*

BMI (kg/m2)

33.2

32.8

0.083*

Past surgery history

 Cesarean

146 (69.5)

157 (74.8)

0.166**

 Appendectomy

7 (3.3)

4 (1.9)

0.781**

 Cholecystectomy

3 (1.4)

4 (1.9)

0.210**

 Laparoscopy

11 (5.2)

9 (4.3)

0.410**

 Ovarian cystectomy

6 (2.9)

6 (2.9)

0.089**

 Curettage

7 (3.3)

2 (1.0)

0.311**

 Colporrhaphy

2 (1.0)

3 (1.4)

0.095**

 No surgical history

28 (13.4)

25 (11.9)

0.510**

Underlying disease

 Gestational diabetes

15 (7.1)

19 (9.0)

0.177**

 Epilepsy

4 (1.9)

5 (2.4)

0.981**

 Gestational hypertension

9 (4.3)

8 (3.8)

0.870**

 Thyroid disorders

11 (5.2)

16 (7.6)

0.561**

 Asthma

5 (2.4)

10 (4.8)

0.210**

 Anemia

7 (3.3)

7 (3.3)

0.957**

 Pre-eclampsia

4 (1.9)

6 (2.9)

0.751**

 No underlying disease

155 (73.8)

139 (66.2)

0.321**

Medications

 Enoxaparin

8 (3.8)

7 (3.3)

0.138**

 Methyldopa

6 (2.9)

10 (4.8)

0.510**

 Levothyroxine

11 (5.2)

16 (7.6)

0.091**

 Ferrous sulfate

7 (3.3)

7 (3.3)

0.581**

 Metformin

4 (1.9)

4 (1.9)

0.134**

 Other

67 (31.9)

58 (27.6)

0.0881**

 No drug

109 (51.9)

103 (49.0)

0.671**

Cesarean section indication

 Past C-section

114 (54.3)

107 (51.0)

0.311**

 Fetal distress

17 (8.1)

17 (8.1)

0.410**

 Multiple pregnancies

12 (6.2)

9 (4.3)

0.870**

 Elective

2 (1.0)

4 (1.9)

0.651**

 Prolonged first stage of labour

12 (6.2)

10 (5.2)

0.810**

 Prolonged second stage of labour

5 (2.4)

5 92.4)

0.079**

 Not responding to induction

11 (5.2)

11 (5.2)

0.095**

 Breech presentation

6 (2.9)

13 (6.2)

0.310**

 Pre-eclampsia

4 (1.9)

4 (1.9)

0.417**

 CPD

5 (2.4)

3 (1.4)

0.639**

 Macrosomia

9 (4.3)

6 (2.9)

0.061**

 Hydrocephalic

5 (2.4)

3 (3.4)

0.123**

 IUGR

4 (1.9)

3 (1.4)

0.077**

 Placenta Previa

4 (1.9)

4 (1.9)

0.271**

  1. CPD Cephalopelvic disproportion, IUGR Intrauterine growth restriction, C-section cesarean section, BMI Body mass index
  2. *Mann–Whitney test/**Fisher's exact test